Stanford Medicine Receives $6 Million for Pediatric Cancer Research

Stanford Medicine Receives $6 Million for Pediatric Cancer Research

Stanford Medicine has announced a $6 million commitment from Tad and Dianne Taube in support of innovative therapies that improve cure rates for childhood cancer.

The gift to establish the Taube Initiative in Pediatric Cancer Research will support researchers at Stanford Medicine and Lucile Packard Children's Hospital Stanford who are exploring promising areas of discovery, including immunotherapies and cancer genomics. To that end, the gift will support two faculty members: the Taube Distinguished Scholar in Pediatric Immunotherapy, who will focus on the development of immunotherapy treatments, which are associated with fewer long-term toxicities than chemotherapy and radiation; and the Taube Distinguished Scholar for Pediatric Oncology, who will lead efforts to develop customized therapies using knowledge of the genetic differences found in cancer cells.

The gift also will support the creation of a Taube Innovation Fund in Pediatric Cancer for innovative research and clinical projects within the Division of Hematology/Oncology in the Department of Pediatrics at the medical school.

With the latest gift, the Taubes have pledged a total of more than $40 million to the Stanford Medicine and Packard Children's, including $20 million for the hospital's main building and $14.5 million to address youth addiction and concussion issues.

"It is essential that we help society's most vulnerable, our children, to beat cancer," said Taube Philanthropies chair Tad Taube, who signed the Giving Pledge in 2013. "Researchers at Stanford, one of the world's preeminent research institutions, are leading the way in the search for better treatments for this dreadful disease. We are proud to support them in their effort to save countless children's lives."

(Photo credit: Susana Bates for Drew Altizer)

"Tad and Dianne Taube Commit $6 Million for Pediatric Cancer Research." Stanford Medicine Press Release 05/01/2019.